UK said 'unlikely' to adopt euro soon

The government has said key economic tests have yet to prove that joining the 16-nation euro zone would benefit Britain.

By
July 15, 2009 09:12

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

It is unlikely that Britain will adopt the euro common currency any time soon, Business Secretary Peter Mandelson said Tuesday. The government has said key economic tests have yet to prove that joining the 16-nation euro zone would benefit Britain. The public also remains skeptical about tying the British economy to that of European neighbors. "The prospect and chances of us joining the single currency early on are not strong," Mandelson told reporters. Though Mandelson has long supported Britain adopting the euro, he said it would take "quite many years, more than I would like," for that to happen. Opinion polls have consistently shown that a public referendum on membership would be rejected.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS